Mephenesin

美芬新

Report date: 2026/04/08 15:32:37
NME

Base Information

Drug NameMephenesin
Drug Alias Namemefenesina甲苯丙醇麦酚生mephenesinum3-(o-Tolyloxy)propane-1,2-diol +[13
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsMuscle Spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMuscle Spasticity
Inactive IndicationsN/A

Other Information

ATC CodeM03BX06
Related LinksWikipediaKEGG